What R2 Technology Services, Inc. does

R2 Technology Services, Inc., operating commercially as Glacial Skin, is a privately held medical device company headquartered in San Ramon, California, founded in 2014 and employing 11-50 staff. The company develops and markets FDA-cleared cryotherapy devices (Glacial Rx and Glacial fx) powered by its proprietary Cryomodulation technology — a controlled-cooling mechanism intended to suppress pro-inflammatory cytokines, increase anti-inflammatory cytokines, and address visible signs of premature aging caused by skin inflammation. Its commercial product line spans two core devices and three treatment protocols (Glacial Gloss Rx, Glacial Glide Rx, and Glacial Freeze), the last of which targets benign lesion removal. R2 holds registered trademarks on Glacial Skin, CryoAesthetics, Cryomodulation, Glacial Rx, and Glacial fx, and positions itself as the category creator for "CryoAesthetics," an aesthetic device segment distinct from conventional cooling technologies.

The company operates a B2B enterprise field sales motion, selling devices directly to aesthetic practices, dermatology clinics, medical spas, and solo estheticians across North America. Pricing is quote-based with multi-year contracts, and there is no publicly disclosed list price. Distribution runs through a direct sales team backed by a Find a Provider locator, the PEAK provider certification program, and a dedicated provider training portal (glacialskin.training). The customer base is overwhelmingly SMB — solo practitioners and small practices — with patient outcomes (100% repeat/recommend rate, 90% patient-reported skin improvement, 92% physician-assessed improvement) cited from internal surveys. Marketing reaches end patients and providers through Instagram, TikTok, Facebook, LinkedIn, YouTube, a branded podcast (The Glam Report), and education events, with a Summer 2026 "biggest offer of the year" promotional campaign actively running to accelerate provider acquisition.

The leadership team comprises Tim Holt as President and CEO, Han Jansen as CFO, and Kristine N. Tatsutani as CSO. R2 is privately held with no disclosed parent company, institutional investor, or funding round details. Geographic operations are restricted to North America, and no financial metrics — revenue, ARR, headcount trend, or burn — are publicly disclosed. The company is actively operating, with continuous product, channel, and category investment visible across its website and social properties.

Name

R2 Technology Services, Inc.

Legal name

R2 Technologies, Inc.

Website

https://r2technologies.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

R2 Technology Services, Inc., operating as Glacial Skin, is a privately held medical device company that develops and sells FDA-cleared cryotherapy devices (Glacial Rx and Glacial fx) using proprietary Cryomodulation technology to address skin inflammation and premature aging, selling direct to aesthetic practices, medical spas, dermatologists, and solo estheticians across North America.

Ownership category

akta.pro rank

Product category

Aesthetic Medical Devices

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hot/Cold Therapy Services (Cryotherapy/Ice Baths) (HSALAFAH)

Keywords

• Cryotherapy devices
• Aesthetic medical devices
• Cryomodulation technology
• Skin inflammation treatment
• Cryoaesthetic systems

Headquarters

HQ city

San Ramon

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Sale of CryoAesthetics medical devices (Glacial Rx and Glacial fx) to aesthetic practices, dermatologists, and skincare clinics. Revenue generated from initial device purchase by provider practices.
2. Treatment Services Revenue: Providers generate revenue through offering cryotherapy treatments to end patients using the Glacial Skin devices

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels9 records

Core offering

R2 Technologies designs, manufactures and sells FDA-cleared Glacial Skin cryotherapy medical devices (Glacial Rx and Glacial fx) that use proprietary Cryomodulation technology to reduce the visible signs of premature aging driven by chronic skin inflammation. The devices are sold as capital equipment to licensed aesthetic providers, dermatology clinics and medical spas, who then perform CryoAesthetics treatments such as Glacial Gloss Rx, Glacial Glide Rx and Glacial Freeze on end patients.

Product overview

R2 Technologies, Inc. offers the Glacial Skin CryoAesthetics product line consisting of two core cryotherapy devices (Glacial Rx and Glacial fx) and three treatment protocols (Glacial Gloss Rx, Glacial Glide Rx, and Glacial Freeze). These products use proprietary Cryomodulation technology, which applies controlled cooling to suppress pro-inflammatory cytokines and increase anti-inflammatory cytokines to calm the skin. The devices are FDA-cleared for use in aesthetic and dermatological practices.

Differentiator

Problem solved

Functional benefit

Brands

• Glacial Rx: FDA-cleared cryomodulation device for controlled cooling treatments to address premature aging, inflammation, and redness. Used for facials and post-procedure recovery.
• Glacial fx
• Glacial Gloss Rx
• Glacial Glide Rx
• Glacial Freeze

Products and services

• Glacial Rx

Quantifiable outcome

• 100% of patients would repeat and recommend Glacial Skin treatments
• +3 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• InMode: Public aesthetic device company with a large portfolio of minimally invasive and energy-based platforms. Aggressively expands into adjacent indications that overlap with R2's anti-inflammation and rejuvenation positioning.
• Venus Concept: Aesthetic device company selling energy-based platforms to medical spas and dermatology practices. Operates a subscription-based business model for devices that competes directly with Glacial Skin's hardware sales.
• Sciton: Premium aesthetic and medical laser platform with strong brand presence in dermatology practices. Competes for the same per-practice device budget with laser- and light-based rejuvenation alternatives.
• Cutera: Established aesthetic laser and energy-based device company serving the same dermatologist and med-spa customer base. Competes for capital-equipment budget at aesthetic practices and offers alternative rejuvenation modalities.
• Cynosure: Major aesthetic device manufacturer with deep distribution across dermatology and medical spa channels. Sells competing energy-based aesthetic platforms that providers may choose instead of or alongside Glacial Skin devices.
• BTL Industries: Aesthetic device leader in body contouring and skin tightening (e.g., Emface, Exilis). Targets the same provider channels and competes for the same elective procedure demand pool as Glacial Skin.
• CoolSculpting (Allergan Aesthetics / AbbVie): Largest cryotherapy-based aesthetic device franchise, focused on body contouring rather than facial rejuvenation. Operates as a broad incumbent in the same underlying cryotherapy category and targets overlapping aesthetic practice customers.
• Alma Lasers: Global aesthetic device company offering a broad portfolio of energy-based platforms to med-spas and dermatology clinics. Provides alternative non-cryo modalities that could substitute for Cryomodulation treatments.
• Solta Medical (Bausch Health): Established aesthetic device brand (Thermage, Clear + Brilliant, Fraxel) serving dermatologists and med-spas. Competes for the same patient demand for non-invasive facial rejuvenation and post-procedure recovery.

Direct peers

• HydraFacial (Edge Systems): Direct peer in B2B aesthetic device sales to medical spas, dermatologists, and skincare practices. Both sell proprietary devices that providers use to deliver recurring branded skin treatments, with comparable go-to-market models targeting SMB aesthetic practices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xinstagram.com/glacial.skin
• YouTubeyoutube.com/channel/UCI3W0ssj_KGrf9VxxEDU3fw
• Facebookfacebook.com/Glacialskintreatments
• LinkedInlinkedin.com/company/r2techofficial
• Instagraminstagram.com/glacial.skin
• TikToktiktok.com/@glacial.skin

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about R2 Technology Services, Inc.